Cediranib: glimmer of hope in glioblastoma

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1635, 2008-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combined Treatment with PPAR-γ Agonists in Pancreatic Cancer: A Glimmer of Hope for Cancer Therapy?

Current Cancer Drug Targets, Vol. 13, Iss. 4, 2013-01 ,pp. : 460-471

Bentham Science Publishers

Access to resources Recommend Favorite

Cediranib/doxorubicin: Hypertension, decreased ejection fraction and hypokinesia (first reports with cediranib): 2 case reports

Reactions Weekly, Vol. 1, Iss. 1159, 2007-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite

Management of glioblastoma

By Aoki Tomokazu Hashimoto Nobuo Matsutani Masao

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 18, 2007-12 ,pp. : 3133-3146

Informa Healthcare

Access to resources Recommend Favorite

Cediranib: Increased levothyroxine sodium requirement (first report) in an elderly patient with hypothyroidism: case report

Reactions Weekly, Vol. 1, Iss. 1208, 2008-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Bevacizumab ± irinotecan beneficial for glioblastoma

Inpharma, Vol. 1, Iss. 1640, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite